KI
SWTX

Kula Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Kula Investments’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$982K Buy
+38,159
New +$1.12M 0.24% 132

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Kula Investments's SWTX Position: Q1 2023 in Review

Kula Investments opened a new position in SpringWorks Therapeutics (SWTX) in Q1 2023: 38,159 shares worth $982K. The stake represents 0.24% of the portfolio and ranks #132 among its holdings.

148 funds tracked by Wall St. Rank hold SWTX as of Q1 2023.

  • Kula Investments held 38,159 shares of SpringWorks Therapeutics worth $982K as of Q1 2023.
  • SpringWorks Therapeutics was a new Kula Investments position in Q1 2023.
  • SpringWorks Therapeutics made up 0.24% of Kula Investments's portfolio in Q1 2023, its #132 holding.
  • 148 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.